Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Date:9/3/2007

DETROIT, Aug. 22 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD) announced today that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Phentermine Hydrochloride Tablets USP, 37.5 mg (Phentermine HCl).

Phentermine HCl is indicated only as short-term monotherapy for the management of exogenous obesity. Our generic Phentermine HCl is the bioequivalent to Adipex-P(R), a registered trademark of TEVA Pharmaceuticals USA, Inc. According to IMS Data, for the twelve months ended June 2007, Phentermine HCl generic and brand products (Adipex-P(R)) combined had annual sales of approximately $34 million.

Daniel H. Movens, Caraco's Chief Executive Officer, said, "We are pleased to gain this approval from the FDA. Our focus continues to be working towards expanding our product line effectively, including products that are already available generically in the market that potentially can add measurable value. We plan to market this product to the generic pharmaceutical market immediately. This will bring our total product selection to 36 different products represented by 74 various strengths."

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward- looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission and include, but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or cheaper products or new technology for the production of products, the entry into the market of new competitors, market and customer acceptance and demand for new pharmaceutical products, availability of raw materials, timing and success of product development and launches, dependence on few products generating majority of sales, product liability claims for which the Company may be inadequately insured, and other risks identified in this report and from time to time in our periodic reports and registration statements. These forward- looking statements represent our judgment as of the date of this report. We disclaim, however, any intent or obligation to update our forward-looking statements.


'/>"/>
SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2020)... ... March 20, 2020 , ... With ICH E8(R1) set to be adopted in ... they do today. Be ready to implement the new guidelines. , The Revised ... to leverage the revised guidelines’ quality-by-design approaches, expanded study designs and data source considerations. ...
(Date:3/16/2020)... ... March 16, 2020 , ... To avoid the ... Human Services Authority is implementing several new universal health and safety measures agency-wide. ... and staff," said Dr. Monteic A. Sizer, executive director of Northeast Delta. "Extensive ...
(Date:3/15/2020)... ... March 13, 2020 , ... Special ... mission to bridge the gap by connecting individuals with autism and other developmental ... to attain fulfilling and independent lives has not wavered. , These past ...
(Date:3/15/2020)... ... March 14, 2020 , ... Amid ... (COVID-19) pandemic, National HouseCheck Corporation (‘HouseCheck’) is bringing their world-class environmental services ... has launched its nationwide Virus Remediation and Decontamination program (the process, protocols ...
(Date:3/13/2020)... ... March 13, 2020 , ... The Berman Law Group today announced that it ... Province, the City of Wuhan, and several Chinese government ministries, on behalf of residents ... filed in the Southern District of Florida, and seeks billions of dollars in compensatory ...
Breaking Medicine News(10 mins):
(Date:3/30/2020)... ... March 30, 2020 , ... In order to provide ... appointments in addition to in-person visits. The San Diego-based leader in regenerative ... patients, health care professionals, and the community at large is the top priority. ...
(Date:3/27/2020)... ... 2020 , ... Nexus, a national nonprofit organization that provides ... Family Healing. For more than 45 years, Nexus has focused on rebuilding lives, ... and behavioral issues. Moving forward, Nexus Family Healing will fulfill that purpose with ...
(Date:3/27/2020)... ... 2020 , ... The Haute Beauty Network, well known for ... a leading weight-loss and Body expert representing the Los Angeles Market and the ... collective of leading doctors nationwide. The invitation-only exclusive network maintains elite as ever, ...
Breaking Medicine Technology: